Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models
NSAID-induced analgesia is typically induced by inhibition of COX enzymes. Here the authors show instead that fenamate NSAIDs inhibit the Nlrp3 inflammasome via an effect on volume-regulated anion channel function and also repurpose these drugs for therapeutic effect in rodent models of Alzheimer di...
Guardado en:
Autores principales: | Michael J. D. Daniels, Jack Rivers-Auty, Tom Schilling, Nicholas G. Spencer, William Watremez, Victoria Fasolino, Sophie J. Booth, Claire S. White, Alex G. Baldwin, Sally Freeman, Raymond Wong, Clare Latta, Shi Yu, Joshua Jackson, Nicolas Fischer, Violette Koziel, Thierry Pillot, James Bagnall, Stuart M. Allan, Pawel Paszek, James Galea, Michael K. Harte, Claudia Eder, Catherine B. Lawrence, David Brough |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dca8360eb57c4ee588985f6c192c8a0c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Redefining the ancestral origins of the interleukin-1 superfamily
por: Jack Rivers-Auty, et al.
Publicado: (2018) -
MICROWAVE-ASSISTED SYNTHESIS OF BENZOFURAN ANALOGS OF FENAMATES AS NON STEROIDAL ANTI-INFLAMMATORY AGENTS
por: MANE,BALASAHEB Y, et al.
Publicado: (2009) -
Editorial: NSAIDs Pharmacogenomics
por: José A. G. Agúndez, et al.
Publicado: (2021) -
Salmonella typhimurium-induced IL-1 release from primary human monocytes requires NLRP3 and can occur in the absence of pyroptosis
por: Catherine E. Diamond, et al.
Publicado: (2017) -
Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani S, et al.
Publicado: (2019)